These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36750471)

  • 21. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. August 2020 Interim EuGMS guidance to prepare European Long-Term Care Facilities for COVID-19.
    Blain H; Rolland Y; Schols JMGA; Cherubini A; Miot S; O'Neill D; Martin FC; Guérin O; Gavazzi G; Bousquet J; Petrovic M; Gordon AL; Benetos A
    Eur Geriatr Med; 2020 Dec; 11(6):899-913. PubMed ID: 33141405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.
    Kimball A; Hatfield KM; Arons M; James A; Taylor J; Spicer K; Bardossy AC; Oakley LP; Tanwar S; Chisty Z; Bell JM; Methner M; Harney J; Jacobs JR; Carlson CM; McLaughlin HP; Stone N; Clark S; Brostrom-Smith C; Page LC; Kay M; Lewis J; Russell D; Hiatt B; Gant J; Duchin JS; Clark TA; Honein MA; Reddy SC; Jernigan JA; ;
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(13):377-381. PubMed ID: 32240128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].
    Perkhofer L; Grünke P; Gashi-Ymeri E; Grünke T; Kroschel J; Michel D; Pensel E; Rost A; Denkinger M; Dallmeier D; Seufferlein T
    Z Gerontol Geriatr; 2021 Aug; 54(5):463-470. PubMed ID: 34259902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort.
    Scanferla G; Héquet D; Graf N; Münzer T; Kessler S; Kohler P; Nussbaumer A; Petignat C; Schlegel M; Flury D
    Swiss Med Wkly; 2023 Mar; 153():40052. PubMed ID: 37011609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of long-term care facility characteristics associated with COVID-19 outcomes.
    Konetzka RT; White EM; Pralea A; Grabowski DC; Mor V
    J Am Geriatr Soc; 2021 Oct; 69(10):2766-2777. PubMed ID: 34549415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington.
    Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
    JAMA Intern Med; 2020 Aug; 180(8):1101-1105. PubMed ID: 32437547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of COVID-19 in Assisted Living Facilities - 39 States, October 2020.
    Yi SH; See I; Kent AG; Vlachos N; Whitworth JC; Xu K; Gouin KA; Zhang S; Slifka KJ; Sauer AG; Kutty PK; Perz JF; Stone ND; Stuckey MJ
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(46):1730-1735. PubMed ID: 33211679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study.
    Arendse T; Cowper B; Cohen C; Masha M; Tempia S; Legodu C; Singh S; Ratau T; Geffen L; Heymans A; Coetzer D; Blumberg L; Jassat W
    BMC Public Health; 2022 May; 22(1):1035. PubMed ID: 35606732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of COVID-19 control measures on post-vaccination outbreak in Italian Long Term Care Facilities: implications for policies.
    Malara A; Noale M; Trevisan C; Abbatecola AM; Borselli G; Cafariello C; Gareri P; Fumagalli S; Mossello E; Volpato S; Monzani F; Coin A; Okoye C; Bellelli G; Del Signore S; Zia G; Antonelli Incalzi R; Palmieri A; Fedele G; Onder G;
    Front Public Health; 2023; 11():1091974. PubMed ID: 37346108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.
    Muhsen K; Maimon N; Mizrahi AY; Boltyansky B; Bodenheimer O; Diamant ZH; Gaon L; Cohen D; Dagan R
    JAMA Intern Med; 2022 Aug; 182(8):859-867. PubMed ID: 35737368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    Smith DRM; Shirreff G; Temime L; Opatowski L
    PLoS Med; 2023 Jun; 20(6):e1004240. PubMed ID: 37276186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.
    Matuschek C; Fischer JC; Combs SE; Fietkau R; Corradini S; Zänker K; Bölke E; Djiepmo-Njanang FJ; Tamaskovics B; Fischer JE; Stuschke M; Pöttgen C; Förster R; Zwahlen DR; Papachristofilou A; Ganswindt U; Pelka R; Schneider EM; Feldt T; Jensen BEO; Häussinger D; Knoefel WT; Kindgen-Milles D; Pedoto A; Grebe O; van Griensven M; Budach W; Haussmann J
    Strahlenther Onkol; 2020 Dec; 196(12):1068-1079. PubMed ID: 32914236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
    Cohen MS; Nirula A; Mulligan MJ; Novak RM; Marovich M; Yen C; Stemer A; Mayer SM; Wohl D; Brengle B; Montague BT; Frank I; McCulloh RJ; Fichtenbaum CJ; Lipson B; Gabra N; Ramirez JA; Thai C; Chege W; Gomez Lorenzo MM; Sista N; Farrior J; Clement ME; Brown ER; Custer KL; Van Naarden J; Adams AC; Schade AE; Dabora MC; Knorr J; Price KL; Sabo J; Tuttle JL; Klekotka P; Shen L; Skovronsky DM;
    JAMA; 2021 Jul; 326(1):46-55. PubMed ID: 34081073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration and impact of COVID-19 in long term care facilities in England: population surveillance study.
    Chudasama DY; Milbourn H; Nsonwu O; Senyah F; Florence I; Cook B; Marchant E; Blomquist PB; Flannagan J; Dabrera G; Lewis J; Lamagni T
    Int J Epidemiol; 2022 Jan; 50(6):1804-1813. PubMed ID: 34999883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidance for the Prevention of the COVID-19 Epidemic in Long-Term Care Facilities: A Short-Term Prospective Study.
    Rolland Y; Lacoste MH; de Mauleon A; Ghisolfi A; De Souto Barreto P; Blain H; Villars H
    J Nutr Health Aging; 2020; 24(8):812-816. PubMed ID: 33009529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Healthcare-associated infections and antimicrobial use in long-term care facilities. German results of the third European point prevalence survey HALT-3].
    Schmidt N; Marujo V; Eckmanns T; Zacher B; Arvand M; Ruscher C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):863-871. PubMed ID: 35951042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid systematic review of measures to protect older people in long-term care facilities from COVID-19.
    Frazer K; Mitchell L; Stokes D; Lacey E; Crowley E; Kelleher CC
    BMJ Open; 2021 Oct; 11(10):e047012. PubMed ID: 34663652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.